These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26187429)

  • 1. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Gastroenterol; 2016 Feb; 51(2):153-61. PubMed ID: 26187429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
    Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma.
    Gerhardt T; Milz S; Schepke M; Feldmann G; Wolff M; Sauerbruch T; Dumoulin FL
    World J Gastroenterol; 2006 Sep; 12(34):5495-500. PubMed ID: 17006987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.
    Sano T; Shimada K; Sakamoto Y; Yamamoto J; Yamasaki S; Kosuge T
    Ann Surg; 2006 Aug; 244(2):240-7. PubMed ID: 16858186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma.
    Asakura R; Yanagimoto H; Ajiki T; Tsugawa D; Mizumoto T; So S; Urade T; Nanno Y; Fukushima K; Gon H; Komatsu S; Kuramitsu K; Goto T; Asari S; Kido M; Toyama H; Fukumoto T
    Dig Surg; 2022; 39(2-3):65-74. PubMed ID: 35051946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma.
    Yoh T; Seo S; Hatano E; Taura K; Fuji H; Ikeno Y; Okuda Y; Yasuchika K; Kaido T; Okajima H; Uemoto S
    Ann Surg Oncol; 2017 May; 24(5):1351-1357. PubMed ID: 28108828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.
    Nagino M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y
    Ann Surg; 2013 Jul; 258(1):129-40. PubMed ID: 23059502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma.
    Oshiro Y; Sasaki R; Fukunaga K; Kondo T; Oda T; Takahashi H; Ohkohchi N
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):389-95. PubMed ID: 23138964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
    Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
    Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.
    Utsumi M; Kitada K; Tokunaga N; Kato T; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    BMC Gastroenterol; 2021 Oct; 21(1):375. PubMed ID: 34645392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
    Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.
    Nagino M
    J Gastroenterol; 2012 Nov; 47(11):1165-76. PubMed ID: 22847554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
    Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.